Arcellx, Inc. (ACLX)
114.77
+0.02
(+0.02%)
USD |
NASDAQ |
Apr 02, 16:00
114.77
0.00 (0.00%)
After-Hours: 20:00
Arcellx Total Liabilities (Quarterly) : 201.64M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 36.40B |
| Eli Lilly & Co. | 85.94B |
| Merck & Co., Inc. | 84.20B |
| Bristol Myers Squibb Co. | 71.53B |
| BioMarin Pharmaceutical, Inc. | 1.507B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 603.99M |
| Shareholders Equity (Quarterly) | 402.35M |
| Debt to Equity Ratio | 0.129 |
| Current Ratio | 4.436 |
| Net Debt Paydown Yield | 0.07% |